Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
暂无分享，去创建一个
J. Baselga | N. Robert | D. Miles | J. O’Shaughnessy | S. Di Cosimo | V. Calvo | A. Brufsky | J. Cortés | C. Saura | A. González‐Martín | M. Bellet | M. Vidal | A. Llombart | E. Muñoz | S. Dawood | J. Pérez | N. Ramírez-Merino | O. Silva | A. González-Martín